Literature DB >> 11599020

Molecular dynamics of HIV-1 reverse transcriptase indicates increased flexibility upon DNA binding.

M Madrid1, J A Lukin, J D Madura, J Ding, E Arnold.   

Abstract

HIV-1 reverse transcriptase (RT) is one of the main targets for drugs used in the treatment of AIDS, among them, the non-nucleoside RT inhibitors (NNRTIs). The flexibility of RT unliganded and complexed to double-stranded DNA (RT/dsDNA), in water, has been studied by means of molecular dynamics. The simulations show that RT flexibility depends on its ligation state. The RT/dsDNA trajectories show larger fluctuations in the atomic positions than uncomplexed RT, particularly at the tips of the p66 fingers and thumb subdomains. This increased flexibility is consistent with the ability of the p66 fingers of the RT/dsDNA complex to close down after the binding of a deoxynucleoside triphosphate (dNTP) molecule, as observed in the crystal structures of RT/dsDNA bound to dNTP. The two complexation states present different patterns of concerted motions, indicating that the bound dsDNA alters RT flexibility. The motions of amino acid residues that form the non-nucleoside RT inhibitor binding pocket upon complexation with a NNRTI are anticorrelated with the p66 fingers (in RT/dsDNA) and correlated to the RNase H subdomain (unliganded RT). These concerted motions indicate that binding of a NNRTI could alter the flexibility of the subdomains whose motions are correlated to those of the binding pocket. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599020     DOI: 10.1002/prot.1137

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  14 in total

1.  The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.

Authors:  Z Sevilya; S Loya; N Adir; A Hizi
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

Review 2.  Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.

Authors:  Nicolas Sluis-Cremer; N Alpay Temiz; Ivet Bahar
Journal:  Curr HIV Res       Date:  2004-10       Impact factor: 1.581

3.  Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.

Authors:  Emmanuele Crespan; Giada A Locatelli; Reynel Cancio; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Unbinding Dynamics of Non-Nucleoside Inhibitors from HIV-1 Reverse Transcriptase.

Authors:  Leela S Dodda; Julian Tirado-Rives; William L Jorgensen
Journal:  J Phys Chem B       Date:  2019-01-03       Impact factor: 2.991

5.  Mining protein dynamics from sets of crystal structures using "consensus structures".

Authors:  Gerard J P van Westen; Jörg K Wegner; Andreas Bender; Adriaan P Ijzerman; Herman W T van Vlijmen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

6.  The dynamics of interconverting D- and E-forms of the HIV-1 integrase N-terminal domain.

Authors:  Balasubramanian Sangeetha; Rajagopalan Muthukumaran; Ramaswamy Amutha
Journal:  Eur Biophys J       Date:  2014-08-09       Impact factor: 1.733

7.  High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzyme.

Authors:  Reynel Cancio; Romano Silvestri; Rino Ragno; Marino Artico; Gabriella De Martino; Giuseppe La Regina; Emmanuele Crespan; Samantha Zanoli; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ.

Authors:  Christal D Sohl; Michal R Szymanski; Andrea C Mislak; Christie K Shumate; Sheida Amiralaei; Raymond F Schinazi; Karen S Anderson; Y Whitney Yin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

9.  The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.

Authors:  Sangeetha Balasubramanian; Muthukumaran Rajagopalan; Ravi Shankar Bojja; Anna Marie Skalka; Mark D Andrake; Amutha Ramaswamy
Journal:  J Biomol Struct Dyn       Date:  2016-11-28

Review 10.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.